Status:
COMPLETED
Cardiovascular Registry of Atrial Fibrillation
Lead Sponsor:
Brazilian Clinical Research Institute
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18+ years
Brief Summary
Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control le...
Detailed Description
Patients will be followed 6 months and 1 year after the baseline visit and will be collected data of antithrombotic therapy, laboratory data, discontinuation rates of antithrombotic therapy and clinic...
Eligibility Criteria
Inclusion
- Age \> 18 years-old that signed informed consent;
- Atrial Fibrillation or Atrial Flutter at the time of inclusion documented in source document;
- If the patient is not in atrial fibrillation or Atrial Flutter rhythm, s/he should have 2 electrographic records, at least 15 days apart between them, with one of them being performed within the last 6 months before enrollment (AF may be documented by 12-lead ECG, Holter monitor-24h);
Exclusion
- Patients who did not agree to participate.
- Patients without possibility of monitoring for one year.
Key Trial Info
Start Date :
August 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
2016 Patients enrolled
Trial Details
Trial ID
NCT04456842
Start Date
August 4 2020
End Date
September 30 2024
Last Update
October 4 2024
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Interzonal General de Agudos "Dr. José Penna"
Bahía Blanca, Buenos Aires, Argentina
2
DIM Clínica Privada
Ramos Mejía, Buenos Aires, Argentina
3
Centro de Investigaciones Medicas Temperley (CIMeT)
Temperley, Buenos Aires, Argentina
4
Hospital Italiano de La Plata
Buenos Aires, La Plata, Argentina